Ronidazole

• UNSPSC Description:

  Ronidazole is a potent and orally active antiprotozoal and anti-microbial agent. Ronidazole acts as a veterinary agent against Tritrichomonas foetus in cats models. Ronidazole can be used the research of forhistomoniasis and swine dysentery[1][2][3].

• Target Antigen:

  Bacterial; Parasite

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/Ronidazole.html

• Purity:

  99.79

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)|H2O : 4 mg/mL (ultrasonic)

• Smiles:

  NC(OCC1=NC=C([N+]([O-])=O)N1C)=O

• Molecular Weight:

  200.15

• References & Citations:

  [1]Jody L Gookin, et al. Efficacy of ronidazole for treatment of feline Tritrichomonas foetus infection. J Vet Intern Med|[2]AbdelKhalek A, et al. Repurposing the Veterinary Antiprotozoal Drug Ronidazole for the Treatment of Clostridioides difficile Infection. Int J Antimicrob Agents. 2020;56(6):106188.|[3]LeVine DN, et al. Ronidazole pharmacokinetics after intravenous and oral immediate-release capsule administration in healthy cats. J Feline Med Surg. 2011;13(4):244-250.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  Launched

• CAS Number:

  7681-76-7